{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-152368","form_type":"8-K","ticker":"IMRX","cik":"0001790340","company_name":"Immuneering Corp","filed_at":"2021-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.146723+00:00","generated_at":"2026-06-27T23:00:46.951773+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Immuneering acquires BioArkive for $8.75M in stock; delays IMM-1-104 IND to Q3 2022","bullets":["Acquired BioArkive for $8.75M in stock (379,635 shares); BioArkive CRO to be fully integrated into Immuneering.","Assumed BioArkive's San Diego lease: 38,613 sq ft, monthly base rent ~$56K, term through April 2032.","IMM-1-104 IND submission delayed to Q3 2022; first patient enrollment now Q4 2022 due to supply chain constraints.","28 BioArkive employees become Immuneering employees; Brett Hall (Immuneering CSO) held majority of BioArkive shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-152368","json":"https://secwatch.observer/filing/0001104659-21-152368.json","markdown":"https://secwatch.observer/filing/0001104659-21-152368.md","text":"https://secwatch.observer/filing/0001104659-21-152368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1790340/000110465921152368/0001104659-21-152368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1790340/000110465921152368/tm2136034d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:00:46.951773+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}